Amiloride modulates alternative splicing in leukemic cells and resensitizes Bcr-AblT315I mutant cells to imatinib.

CMUR > College of Chinese Medicine > Graduate Institute of Integrated Medicine > Journal articles > Item 310903500/47227

Please use this identifier to cite or link to this item: http://ir.cmu.edu.tw/ir/handle/310903500/47227

Title:	Amiloride modulates alternative splicing in leukemic cells and resensitizes Bcr-AblT315I mutant cells to imatinib.
Authors:	(Chang WH);(Liu TC);楊文光(Wen-Kuang Yang);(Lee CC);(Lin YH);(Chen TY);張建國(Jan-Gowth Chang)*
Contributors:	中醫學院中西醫結合研究所;中國附醫院長室
Keywords:	Bcr-AblT315I Mutant Cells
Date:	2011-01
Issue Date:	2012-12-20 15:34:25 (UTC+8)
Relation:	CANCER RESEARCH 71(2):383-392
Appears in Collections:	[Graduate Institute of Integrated Medicine] Journal articles

Files in This Item:

File	Size	Format
AA-B100_20121012150938.docx	679Kb	Unknown	164	View/Open